Advertisement
Advertisement
U.S. Markets close in 1 hr 39 mins
Advertisement
Advertisement
Advertisement
Advertisement

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
7.62+0.07 (+0.93%)
As of 02:21PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.55
Open7.57
Bid7.59 x 2200
Ask7.60 x 4000
Day's Range7.48 - 7.64
52 Week Range7.23 - 10.50
Volume5,537,344
Avg. Volume9,849,803
Market Cap8.405B
Beta (5Y Monthly)1.22
PE Ratio (TTM)11.55
EPS (TTM)0.66
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 27, 2017
1y Target Est11.36
  • Business Wire

    Teva Announces Appointment of New Global R&D and Chief Medical Officer

    TEL AVIV, Israel, July 01, 2022--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eric A. Hughes, MD, PhD as Executive Vice President, Global R&D and Chief Medical Officer. Dr. Hughes will begin his employment on August 1, 2022, and will be based out of Teva's U.S. headquarters in Parsippany, NJ.

  • Business Wire

    Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022

    TEL AVIV, Israel, June 29, 2022--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2022 financial results on Wednesday, July 27, 2022 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.

  • Motley Fool

    2 Buffett Stocks That Outperformed the S&P During the Great Recession

    There are two things that Teva Pharmaceutical Industries (NYSE: TEVA) and Amazon (NASDAQ: AMZN) have in common. While the index fell by 38% during that time, the healthcare company climbed 10% in value, and the tech giant's 8% decline was modest by comparison. Teva provides patients with generic medications that are much cheaper than brand-name drugs.

Advertisement
Advertisement